Dabas Cancer Institute is categorized under Physicians Offices in San Antonio, TX and active since 2003.
Dabas Cancer Institute was established in 2003, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Robin Lenz, Administrator at the company’s single location by writing to 12501 Judson Road # 102, San Antonio, Texas TX 78233 or by phoning (210) 656-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dabas Cancer Institute |
| Contact Person: | Robin Lenz, Administrator |
| Address: | 12501 Judson Road # 102, San Antonio, Texas 78233 |
| Phone Number: | (210) 656-5100 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Dabas Cancer Institute was started in 2003 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Robin Lenz, Administrator for inquiries that concern Dabas Cancer Institute by calling the company number (210) 656-5100, as your correspondence is most welcome. Additionally, the physical location of the single location of Dabas Cancer Institute can be found at the coordinates 29.551177,-98.348583 as well as the street address 12501 Judson Road # 102 in San Antonio, Texas 78233.
For its online presence, you may visit Dabas Cancer Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.